BATTAGLIA, MARIO ALBERTO
 Distribuzione geografica
Continente #
EU - Europa 646
AS - Asia 73
SA - Sud America 15
NA - Nord America 7
Totale 741
Nazione #
IT - Italia 645
SG - Singapore 34
CN - Cina 18
VN - Vietnam 18
BR - Brasile 13
US - Stati Uniti d'America 6
AR - Argentina 2
BD - Bangladesh 1
GB - Regno Unito 1
HK - Hong Kong 1
IR - Iran 1
MX - Messico 1
Totale 741
Città #
Genoa 483
Vado Ligure 84
Rapallo 57
Genova 15
Beijing 6
Ashburn 5
Singapore 5
Bordighera 4
Ho Chi Minh City 4
Hanoi 3
Biên Hòa 2
Guaporé 2
Iguape 2
Berazategui 1
Brooklyn 1
Bạc Liêu 1
Can Tho 1
Coromandel 1
Cotia 1
Da Nang 1
Gramado 1
Hong Kong 1
Hải Dương 1
Itapipoca 1
Jandira 1
Jequié 1
Linfen 1
London 1
Mexico City 1
Oristano 1
Quảng Ngãi 1
Rio de Janeiro 1
San Justo 1
Sapucaia do Sul 1
Thái Nguyên 1
Vila Velha 1
Vĩnh Long 1
Vũng Tàu 1
Totale 697
Nome #
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 111
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis 103
Prevalence of multiple sclerosis in Liguria region, Italy: an estimate using the capture–recapture method 90
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: who gains from it? 67
Occupational outcomes of people with multiple sclerosis: a scoping review 66
Work Difficulties in People with Multiple Sclerosis 60
Study protocol: Exploratory trial of Forza™, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosis 55
First Wave of COVID-19 Pandemic in Italy: Data and Evidence 54
Standard versus innovative robotic balance assessment for people with multiple sclerosis: a correlational study 50
An internet- and Kinect-based Multiple Sclerosis Fitness Intervention Training with Pilates exercises: Development and Usability study 46
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a multi-center, randomized, double blind, cross-over phase 2 clinical trial with autologous mesenchymal stem cells (MSC) 30
[Registers as central real world data source: the experience of the Italian Multiple Sclerosis and Related Disorders Register] 29
Totale 761
Categoria #
all - tutte 3.686
article - articoli 3.198
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 488
Totale 7.372


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202221 0 0 0 0 0 0 0 0 9 2 2 8
2022/202371 6 7 2 6 9 7 0 4 10 5 13 2
2023/202477 6 10 2 10 7 4 5 7 4 2 5 15
2024/2025311 18 11 11 17 24 24 29 55 10 25 57 30
2025/2026281 78 13 50 63 71 6 0 0 0 0 0 0
Totale 761